Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), recently announced the retirement of its Managing Director Thomas Otto after more than 35 years at the company. He will step down at the end of 2025.

Through his clear leadership and commitment, Thomas Otto has been instrumental in shaping the sustainable development and continued growth of the company. As a partner to global biopharmaceutical companies for the production of life-enhancing medicines, Vetter’s success is partially due to his strong and reliable leadership alongside his management colleagues.

“Thomas Otto has decisively advanced our family business with his vision, innovative strength and great sense of responsibility. His contribution to Vetter’s development and internationalization is outstanding and deserves the highest recognition,” says Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family. “For more than three decades, he was a reliable designer, initiator and bridge builder – both within the company and externally. On behalf of the Vetter family and the advisory board, I would like to thank him for his extraordinary commitment and lasting impact on our success story.”

“I am grateful for the many years at Vetter and proud of what we have achieved together. I am extremely pleased that I was able to contribute to making the company strong and fit to take on the future. I wish my colleagues in the management team continued success in leading Vetter with competence and passion,” shared Thomas Otto.

In his advisory role, he will contribute his extensive knowledge and decades of experience with pharmaceutical construction projects to the planned development of a new production site in Germany.

The strategic planning for the new structure of the Vetter management team already started earlier. Long-term experienced Vetter executives Henryk Badack, Titus Ottinger and Carsten Press were appointed to the Management Board as Managing Directors at the beginning of 2025. With their in-depth understanding of the company, its customers and the industry, they are making a significant contribution to Vetter’s sustainable future and the trust towards the owner family and the company Advisory Board.

Vetter remains a trusted partner for its customers, employees, partners and the region. The globally active CDMO continues to stand for quality and stability, strong partnerships and sustainable development. In close collaboration with its customers, the company significantly contributes that life-enhancing medicines are readily available to help patients around the world achieve a better quality of life.

Vetter is a leading Contract Development and Manufacturing Organization (CDMO) with headquarters in Ravensburg, Germany, and production facilities in Germany, Austria, and the US. As a global player, the independent pharmaceutical service provider is also present in the Asia-Pacific markets of Japan, China, South Korea and Singapore with sales locations. Around the world, small and large renowned pharma and biotech companies rely on the decades of experience, high quality, modern technologies, reliability, and commitment of its more than 7,300 employees. In close partnership with its customers, the Vetter team supplies patients all over the world with medicines, many of which are vital. The CDMO provides support from drug product development through clinical and commercial filling to a wide range of assembly and packaging services for vials, syringes, and cartridges. With innovative solutions, Vetter develops prefilled drug-delivery systems together with its customers to continuously improve patient safety, comfort, and compliance. The company is an industry pioneer in sustainability and a socially and ethically responsible corporate citizen. The CDMO is a member of the UN Global Compact and Science Based Target initiative (SBTi) and received gold status in the renowned EcoVadis ranking. Multiple awards such as the CDMO Leadership Awards, Frost & Sullivan Customer Value Leadership Award and the recognition as Best Managed Company emphasize Vetter’s commitment to sustainable business. Founded in Ravensburg in 1950, the company remains family-owned to this day. For more information, visit www.vetter-pharma.com and follow Vetter on LinkedIn.